WEBINAR ENDED
WEBINAR DETAILS
  • About
    FG001 is proven safe in patients undergoing surgery for cancer – a significant milestone for FluoGuide to further advance clinical development in aggressive brain cancer and in a prevalent indication.

    This investor call will allow investors to learn more about the news announced on October 8, 2021.
  • Agenda
    • Presentation of safety data
    • Future outlook
    • Q&A
  • Duration
    1 hour
  • Price
    Free
  • Language
    English
  • OPEN TO
    Everyone
  • Dial-in Number
    Please register for this Webinar to view the dial-in info.
FEATURED PRESENTERS
HOSTED BY
ATTENDED (40)